SURPASS-2, NEJM 2021 An important caveat: semaglutides proven cardiovascular benefit is a meaningful clinical differentiator
Alternative GLP-1 medications Semaglutide is not the only GLP-1 option
Indeed, the history of anti-obesity medications has been marked by several failures due to serious adverse events, such as suicidality, observed only after their usage had become extensive 221,234 a well-known example being the one that led to the withdrawal of the endocannabinoid inverse agonist, rimonabant 235
Inadequate protein intake, reduced physical activity, and dehydration may also contribute
Linda Bluestein: Welcome back, every bendy body, to the Bendy Bodies Podcast
Two of the most talked-about peptides in the health and wellness world today are MOTS-C and Semaglutide